Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Alberta

$42,000.00

Functions of Rdp1 in gene-silencing processes

FY 2007-08

Summary
RNA interference (RNAi) is arguably the most important biological discovery of the past 10-15 years. The application of this technology to molecular medicine has the potential to revolutionize the treatment of many genetic diseases (cancer) and infectious diseases (AIDS, Hepatitis C). Large scale RNAi screens are now being used to systematically knockout the function of known genes in many organisms. The rationale is that by understanding how genes function in the context of normal cellular physiology, we will be in a stronger position to appreciate the molecular mechanisms of genetic diseases. In addition, RNAi can be used to regulate gene expression in organisms much easier than conventional knockout technologies which typically rely on homologous recombination. In plants and fungi, RNAi-dependent gene-silencing requires the activity of RNA-dependent RNA polymerase. This enzyme is required for silencing chromatin in the nucleus as well as post-transcriptional gene-silencing in the cytoplasm. Our laboratory is engaged in understanding how this enzyme functions to requlate two genetically and biochemically distinct gene-silencing pathways in the nucleus and cytoplasm. The outcome of these studies may have implications for regulating gene expression in commercially and/or medically important plant varieities.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
183820-2006
Name nom
Hobman, Tom
Department département
Cell Biology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
42000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
2
Nb partie
5
Application title
Functions of Rdp1 in gene-silencing processes
Keyword
NA
Application summary
RNA interference (RNAi) is arguably the most important biological discovery of the past 10-15 years. The application of this technology to molecular medicine has the potential to revolutionize the treatment of many genetic diseases (cancer) and infectious diseases (AIDS, Hepatitis C). Large scale RNAi screens are now being used to systematically knockout the function of known genes in many organisms. The rationale is that by understanding how genes function in the context of normal cellular physiology, we will be in a stronger position to appreciate the molecular mechanisms of genetic diseases. In addition, RNAi can be used to regulate gene expression in organisms much easier than conventional knockout technologies which typically rely on homologous recombination. In plants and fungi, RNAi-dependent gene-silencing requires the activity of RNA-dependent RNA polymerase. This enzyme is required for silencing chromatin in the nucleus as well as post-transcriptional gene-silencing in the cytoplasm. Our laboratory is engaged in understanding how this enzyme functions to requlate two genetically and biochemically distinct gene-silencing pathways in the nucleus and cytoplasm. The outcome of these studies may have implications for regulating gene expression in commercially and/or medically important plant varieities.